Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
ONS

Oncobiologics

$0.64

-0.036 (-5.31%)

, OTLK

Outlook Therapeutics

$0.00

(0.00%)

09:19
12/03/18
12/03
09:19
12/03/18
09:19
Hot Stocks
Oncobiologics changes name to Outlook Therapeutics »

Oncobiologics (ONS)…

ONS

Oncobiologics

$0.64

-0.036 (-5.31%)

OTLK

Outlook Therapeutics

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Over a month ago
ONS

Oncobiologics

$0.98

0.08 (8.89%)

09:02
11/06/18
11/06
09:02
11/06/18
09:02
Hot Stocks
Oncobiologics receives equity financing committment for $20M »

Oncobiologics announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ONS

Oncobiologics

$0.98

0.08 (8.89%)

09:01
11/06/18
11/06
09:01
11/06/18
09:01
Hot Stocks
Oncobiologics advances ONS-5010 into wet AMD clinical trial »

Oncobiologics announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Over a quarter ago
ONS

Oncobiologics

$0.89

0.04 (4.71%)

08:11
08/02/18
08/02
08:11
08/02/18
08:11
Hot Stocks
Oncobiologics appointsCFO Lawrence Kenyon as CEO »

Oncobiologics announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ONS

Oncobiologics

$0.89

(0.00%)

09:02
07/11/18
07/11
09:02
07/11/18
09:02
Hot Stocks
Oncobiologics regains compliance with Nasdaq listing requirements »

Oncobiologics announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ONS

Oncobiologics

$0.88

-0.0199 (-2.21%)

15:08
06/13/18
06/13
15:08
06/13/18
15:08
Hot Stocks
Oncobiologics announces first CDMO contract »

Oncobiologics announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ONS

Oncobiologics

$1.15

-0.05 (-4.17%)

16:39
02/13/18
02/13
16:39
02/13/18
16:39
Hot Stocks
Oncobiologics receives positive Nasdaq listing determination »

Oncobiologics announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SBUX

Starbucks

$57.99

-2.56 (-4.23%)

, CBS

CBS

$58.95

-1.05 (-1.75%)

10:25
01/29/18
01/29
10:25
01/29/18
10:25
Downgrade
On The Fly: Top five analyst downgrades »

Catch up on today's…

SBUX

Starbucks

$57.99

-2.56 (-4.23%)

CBS

CBS

$58.95

-1.05 (-1.75%)

ONS

Oncobiologics

$1.20

0.01 (0.84%)

ADS

Alliance Data

$259.16

-2.69 (-1.03%)

FTS

Fortis

$34.56

-0.765 (-2.17%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Feb

  • 15

    Feb

ONS

Oncobiologics

$1.20

0.01 (0.84%)

05:02
01/29/18
01/29
05:02
01/29/18
05:02
Downgrade
Oncobiologics rating change at Barclays »

Oncobiologics downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.